Skygene Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2013.
2013 Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Skygene Pharmaceutical Private Limited

Skygene Pharmaceutical Private Limited, a struck off private limited company, was established on 16 September 2013 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51397DL2013PTC257862. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Shailendra Bahadur Pal (Director), Archana Yadav (Additional Director). Past directors included Sanjay Kumar Yadav. Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at C-7,First Floor Madhu Vihar,Sai Chowk,I.P Extention, Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397DL2013PTC257862

  • Registration Number

    257862

  • Incorporation Date

    16 September 2013

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 4 Months
  • Last Filing with ROC 31 Mar 2015
Company report

Skygene Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Skygene Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Skygene Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Shailendra Bahadur Pal Director 16 Sep 2013 Current
Archana Yadav Additional Director 01 Jan 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 11 Jan 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Skygene Pharmaceutical.

Enhance accessibility to Skygene Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Skygene Pharmaceutical revenue growth over time
Skygene Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Skygene Pharmaceutical?

Unlock access to Skygene Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Skygene Pharmaceutical?

Unlock and access historical data on people associated with Skygene Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Skygene Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skygene Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Skygene Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    The activity Archana Yadav was appointed as a Additional Director was appointed as a Additional Director on 01 Jan 2016 & has been associated with this company since 10 years 1 month . was completed.

  • Annual General Meeting

    The activity Skygene Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was completed.

  • Balance Sheet

    Skygene Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    The activity Shailendra Bahadur Pal was appointed as a Director was appointed as a Director on 16 Sep 2013 & has been associated with this company since 12 years 4 months . was completed.

  • Company Incorporation

    Skygene Pharmaceutical Private Limited was registered on 16 Sep 2013 with Roc Delhi & aged 12 years 4 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Skygene Pharmaceutical Private Limited?

The CIN of Skygene Pharmaceutical Private Limited is U51397DL2013PTC257862.

Where is Skygene Pharmaceutical Private Limited headquartered?

Skygene Pharmaceutical Private Limited is headquartered at C-7,First Floor Madhu Vihar,Sai Chowk,I.P Extention, Delhi, Delhi, 110092.

When was Skygene Pharmaceutical Private Limited incorporated?

Skygene Pharmaceutical Private Limited was incorporated on 16 September 2013.

Who are the current directors of Skygene Pharmaceutical Private Limited?

The current directors of Skygene Pharmaceutical Private Limited are

What is the primary industry of Skygene Pharmaceutical Private Limited?

The primary industry of Skygene Pharmaceutical Private Limited is Pharma.

Is Skygene Pharmaceutical Private Limited a listed company?

Skygene Pharmaceutical Private Limited is unlisted.

What is the capital structure of Skygene Pharmaceutical Private Limited?

The authorized capital of Skygene Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available